Literature DB >> 33393073

Farnesoid X receptor: a potential therapeutic target in multiple organs.

Chao Zhang1, Zixuan Wang1, Qingqing Feng1, Wei-Dong Chen2,3, Yan-Dong Wang4.   

Abstract

Farnesoid X receptor (FXR), a member of the nuclear receptor family, is a common receptor found in the intestine and liver, and helps to maintain systemic metabolic homeostasis through regulating bile acid, glucose, lipid metabolism, and energy homeostatsis. In addition, FXR regulates the functions of various organs, such as liver, intestine, kidney, breast, pancreas, cardiovascular system and brain. FXR also plays a key role in regulation of gut-microbiota through mediating the various signaling pathways. Accordingly, FXR has become an attractive therapeutic target in a variety of diseases. This review combines classical and recent research reports to introduce the basic information about FXR and its important roles in various organs of the body.

Entities:  

Year:  2021        PMID: 33393073     DOI: 10.14670/HH-18-301

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  128 in total

Review 1.  Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications.

Authors:  Gloria Alvarez-Sola; Iker Uriarte; Maria U Latasa; Maddalen Jimenez; Marina Barcena-Varela; Eva Santamaría; Raquel Urtasun; Carlos Rodriguez-Ortigosa; Jesús Prieto; Pedro Berraondo; Maite G Fernandez-Barrena; Carmen Berasain; Matías A Avila
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-12       Impact factor: 5.187

Review 2.  Natural history of cirrhosis.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Curr Gastroenterol Rep       Date:  2013-02

3.  An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers.

Authors:  Amani Al-Khaifi; Mats Rudling; Bo Angelin
Journal:  Gastroenterology       Date:  2018-06-19       Impact factor: 22.682

4.  Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts.

Authors:  Ines Barone; Valentina Vircillo; Cinzia Giordano; Luca Gelsomino; Balázs Győrffy; Roberta Tarallo; Antonio Rinaldi; Giuseppina Bruno; Antonella Caruso; Francesco Romeo; Daniela Bonofiglio; Sebastiano Andò; Stefania Catalano
Journal:  Cancer Lett       Date:  2018-09-01       Impact factor: 8.679

Review 5.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

6.  The association of nonalcoholic steatohepatitis and hepatocellular carcinoma.

Authors:  Mohammad Maysara Asfari; Muhammad Talal Sarmini; Mohammad Alomari; Rocio Lopez; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-12       Impact factor: 2.586

Review 7.  Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.

Authors:  Grazia Arpino; Lisa Wiechmann; C Kent Osborne; Rachel Schiff
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

8.  Activation of the Farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential.

Authors:  Noura Alasmael; Rati Mohan; Lisiane B Meira; Karen E Swales; Nick J Plant
Journal:  Cancer Lett       Date:  2015-11-03       Impact factor: 8.679

Review 9.  Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection.

Authors:  Christopher L Bowlus
Journal:  Hepat Med       Date:  2016-09-01

10.  Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease.

Authors:  Britt A Blokker; Monica Maijo; Marta Echeandia; Mikel Galduroz; Angela M Patterson; Anna Ten; Mark Philo; Rebecca Schungel; Virginia Gutierrez-de Juan; Emina Halilbasic; Claudia Fuchs; Gwenaelle Le Gall; Malgorzata Milkiewicz; Piotr Milkiewicz; Jesus M Banales; Simon M Rushbrook; José M Mato; Michael Trauner; Michael Müller; María Luz Martínez-Chantar; Marta Varela-Rey; Naiara Beraza
Journal:  Hepatology       Date:  2019-02       Impact factor: 17.425

View more
  1 in total

Review 1.  The Role of Endoplasmic Reticulum Stress and NLRP3 Inflammasome in Liver Disorders.

Authors:  Xueqin Lu; Haitao Huang; Xiaodi Fu; Chaoran Chen; Huiyang Liu; Honggang Wang; Dongdong Wu
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.